Mountain Pacific Investment Advisers Inc Danaher Corp Transaction History

Mountain Pacific Investment Advisers Inc

$1.42 Billion
Q3 2024

A detailed history of Mountain Pacific Investment Advisers Inc transactions in Danaher Corp stock. As of the latest transaction made, Mountain Pacific Investment Advisers Inc holds 210,556 shares of DHR stock, worth $49.5 Million. This represents 4.12% of its overall portfolio holdings.

Number of Shares

210,556

Previous 208,914 0.79%

Holding current value

$49.5 Million

Previous $52.2 Million 12.14%

% of portfolio

4.12%

Previous 3.95%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$239.25 - $280.76 $392,848 - $461,007	1,642 Added 0.79%	210,556 $58.5 Million
Q2 2024 Jul 10, 2024	SELL	$235.51 - $267.98 $12.6 Million - $14.3 Million	-53,533 Reduced 20.4%	208,914 $52.2 Million
Q1 2024 Apr 11, 2024	SELL	$224.58 - $256.19 $260,512 - $297,180	-1,160 Reduced 0.44%	262,447 $65.5 Million
Q4 2023 Feb 02, 2024	BUY	$185.1 - $233.13 $101,619 - $127,988	549 Added 0.21%	263,607 $61 Million
Q3 2023 Oct 20, 2023	SELL	$233.08 - $265.59 $283,658 - $323,223	-1,217 Reduced 0.46%	263,058 $65.3 Million
Q2 2023 Jul 26, 2023	SELL	$224.99 - $256.14 $353,909 - $402,908	-1,573 Reduced 0.59%	264,275 $63.4 Million
Q1 2023 May 23, 2023	SELL	$239.75 - $277.0 $843,200 - $974,209	-3,517 Reduced 1.31%	265,848 $67 Million
Q4 2022 Jan 20, 2023	SELL	$241.42 - $282.29 $12,553 - $14,679	-52 Reduced 0.02%	269,365 $0
Q3 2022 Oct 13, 2022	SELL	$247.06 - $1507.4 $2.28 Million - $13.9 Million	-9,243 Reduced 3.32%	269,417 $69.6 Million
Q2 2022 Jul 21, 2022	SELL	$237.11 - $299.66 $510,023 - $644,568	-2,151 Reduced 0.77%	278,660 $70.6 Million
Q1 2022 Apr 19, 2022	SELL	$257.27 - $315.76 $847,190 - $1.04 Million	-3,293 Reduced 1.16%	280,811 $82.4 Million
Q4 2021 Jan 19, 2022	SELL	$292.08 - $329.01 $1.77 Million - $1.99 Million	-6,049 Reduced 2.08%	284,104 $93.5 Million
Q3 2021 Oct 25, 2021	SELL	$272.21 - $332.43 $672,358 - $821,102	-2,470 Reduced 0.84%	290,153 $88.3 Million
Q2 2021 Aug 16, 2021	SELL	$225.08 - $271.69 $2.49 Million - $3 Million	-11,047 Reduced 3.64%	292,623 $78.5 Million
Q1 2021 Apr 14, 2021	SELL	$212.38 - $245.9 $961,656 - $1.11 Million	-4,528 Reduced 1.47%	303,670 $68.4 Million
Q4 2020 Jan 21, 2021	SELL	$212.5 - $245.46 $2.84 Million - $3.29 Million	-13,386 Reduced 4.16%	308,198 $68.5 Million
Q3 2020 Oct 13, 2020	SELL	$177.16 - $215.33 $3.27 Million - $3.98 Million	-18,484 Reduced 5.44%	321,584 $69.2 Million
Q2 2020 Jul 09, 2020	SELL	$128.7 - $176.83 $2.17 Million - $2.98 Million	-16,875 Reduced 4.73%	340,068 $60.1 Million
Q1 2020 Apr 08, 2020	SELL	$121.39 - $169.05 $298,619 - $415,863	-2,460 Reduced 0.68%	356,943 $49.4 Million
Q4 2019 Jan 21, 2020	SELL	$133.47 - $153.48 $136,139 - $156,549	-1,020 Reduced 0.28%	359,403 $55.2 Million
Q3 2019 Oct 15, 2019	SELL	$135.4 - $146.47 $390,358 - $422,273	-2,883 Reduced 0.79%	360,423 $52.1 Million
Q2 2019 Jul 23, 2019	SELL	$124.88 - $143.73 $152,353 - $175,350	-1,220 Reduced 0.33%	363,306 $51.9 Million
Q1 2019 May 07, 2019	SELL	$97.62 - $132.29 $163,025 - $220,924	-1,670 Reduced 0.46%	364,526 $48.1 Million
Q4 2018 Jan 25, 2019	BUY	$94.85 - $109.54 $118,657 - $137,034	1,251 Added 0.34%	366,196 $37.8 Million
Q3 2018 Nov 14, 2018	SELL	$98.13 - $108.9 $466,706 - $517,928	-4,756 Reduced 1.29%	364,945 $39.7 Million
Q2 2018 Jul 25, 2018	BUY	$96.1 - $103.24 $33,250 - $35,721	346 Added 0.09%	369,701 $36.5 Million
Q1 2018 Apr 30, 2018	SELL	$92.16 - $103.8 $205,793 - $231,785	-2,233 Reduced 0.6%	369,355 $36.2 Million
Q4 2017 Jan 23, 2018	SELL	$85.26 - $94.62 $485,726 - $539,050	-5,697 Reduced 1.51%	371,588 $34.5 Million
Q3 2017 Oct 20, 2017	BUY	$79.29 - $88.45 $29.9 Million - $33.4 Million	377,285	377,285 $32.4 Million

Others Institutions Holding DHR

# of Institutions

2,508

Shares Held

542M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $171B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mountain Pacific Investment Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mountain Pacific Investment Advisers Inc with notifications on news.

Account

Mountain Pacific Investment Advisers Inc Danaher Corp Transaction History